← Back to FDC Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
FDCPharmaceuticals

FDC Ltd — Profit & Loss Statement

₹321.10
-2.67%

FDC Ltd Profit & Loss Statement (Annual)

Metric20252024202320222021
Tax Effect Of Unusual Items6.15 Cr0.004.01 Cr11.65 Cr—
Tax Rate For Calcs0.250.230.250.25—
Normalized EBITDA391.16 Cr440.17 Cr284.16 Cr283.15 Cr—
Total Unusual Items24.30 Cr64.73 Cr16.16 Cr46.05 Cr—
Total Unusual Items Excluding Goodwill24.30 Cr64.73 Cr16.16 Cr46.05 Cr—
Net Income From Continuing Operation Net Minority Interest266.79 Cr305.22 Cr194.04 Cr216.40 Cr—
Reconciled Depreciation53.73 Cr39.92 Cr38.94 Cr37.30 Cr—
Reconciled Cost Of Revenue736.28 Cr656.15 Cr683.73 Cr547.45 Cr—
EBITDA415.46 Cr440.17 Cr300.31 Cr329.19 Cr—
EBIT361.73 Cr400.25 Cr261.37 Cr291.89 Cr—
Net Interest Income-4.51 Cr-4.03 Cr19.73 Cr19.95 Cr—
Interest Expense4.51 Cr4.03 Cr3.57 Cr2.50 Cr—
Normalized Income248.64 Cr305.22 Cr181.89 Cr182.01 Cr—
Net Income From Continuing And Discontinued Operation266.79 Cr305.22 Cr194.04 Cr216.40 Cr—
Total Expenses1.84K Cr1.64K Cr1.57K Cr1.31K Cr—
Diluted Average Shares16.28 Cr16.28 Cr16.62 Cr16.88 Cr—
Basic Average Shares16.28 Cr16.28 Cr16.62 Cr16.88 Cr—
Diluted EPS16.391858.0011.6712.82—
Basic EPS16.391858.0011.6712.82—
Diluted NI Availto Com Stockholders266.79 Cr305.22 Cr194.04 Cr216.40 Cr—
Net Income Common Stockholders266.79 Cr305.22 Cr194.04 Cr216.40 Cr—
Otherunder Preferred Stock Dividend0.000.000.000.00—
Net Income266.79 Cr305.22 Cr194.04 Cr216.40 Cr—
Minority Interests0.000.16 Cr0.21 Cr0.24 Cr—
Net Income Including Noncontrolling Interests266.79 Cr305.06 Cr193.83 Cr216.16 Cr—
Net Income Continuous Operations266.79 Cr305.06 Cr193.83 Cr216.16 Cr—
Tax Provision90.43 Cr91.16 Cr63.98 Cr73.23 Cr—
Pretax Income357.22 Cr396.22 Cr257.80 Cr289.39 Cr—
Other Non Operating Income Expenses66.36 Cr101.63 Cr1.50 Cr2.17 Cr—
Net Non Operating Interest Income Expense-4.51 Cr-4.03 Cr19.73 Cr19.95 Cr—
Interest Expense Non Operating4.51 Cr4.03 Cr3.57 Cr2.50 Cr—
Operating Income271.07 Cr298.62 Cr212.25 Cr216.78 Cr—
Operating Expense1.10K Cr988.17 Cr881.84 Cr759.11 Cr—
Other Operating Expenses564.68 Cr534.85 Cr255.79 Cr208.34 Cr—
Depreciation And Amortization In Income Statement53.73 Cr39.92 Cr38.94 Cr37.30 Cr—
Depreciation Income Statement53.73 Cr39.92 Cr30.16 Cr29.53 Cr—
Gross Profit1.37K Cr1.29K Cr1.09K Cr975.89 Cr—
Cost Of Revenue736.28 Cr656.15 Cr683.73 Cr547.45 Cr—
Total Revenue2.11K Cr1.94K Cr1.78K Cr1.52K Cr—
Operating Revenue2.11K Cr1.94K Cr1.78K Cr1.52K Cr—
Write Off—0.000.22 Cr-4.60 Cr0.00
Interest Income—30.37 Cr23.82 Cr23.04 Cr11.99 Cr
Rent Expense Supplemental—0.51 Cr0.15 Cr0.09 Cr0.24 Cr
Special Income Charges—4.48 Cr0.69 Cr5.60 Cr-1.45 Cr
Other Special Charges—-4.48 Cr-0.91 Cr-1.00 Cr1.45 Cr
Total Other Finance Cost—0.49 Cr0.52 Cr0.59 Cr0.67 Cr
Interest Income Non Operating—30.37 Cr23.82 Cr23.04 Cr11.99 Cr
Amortization—9.01 Cr8.78 Cr7.77 Cr7.55 Cr
Research And Development—18.48 Cr17.10 Cr15.85 Cr13.26 Cr
Selling General And Administration—184.74 Cr164.80 Cr140.39 Cr81.22 Cr
Selling And Marketing Expense—162.25 Cr147.60 Cr127.59 Cr68.76 Cr
General And Administrative Expense—22.50 Cr17.20 Cr12.80 Cr12.46 Cr
Rent And Landing Fees—0.51 Cr0.15 Cr0.09 Cr0.24 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on FDC Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.